RNA interference-mediated reduction in GLUT1 inhibits serum-induced glucose transport in primary human skeletal muscle cells

Biochem Biophys Res Commun. 2003 Jul 18;307(1):127-32. doi: 10.1016/s0006-291x(03)01124-0.

Abstract

Using RNA interference (RNAi), we specifically down-regulate protein expression in differentiated human skeletal myotube cultures. Serum stimulation of myotubes increases glucose uptake. Using a sensitive photolabeling technique, we demonstrate that this increase in glucose uptake is accompanied by increased cell-surface content of glucose transporter (GLUT) 1. Using RNAi, we specifically reduce GLUT1 mRNA and protein expression, leading to inhibition of serum-mediated increase in glucose transport. Thus, we demonstrate the utility of RNAi in a primary human differentiated cell system, and apply this methodology to demonstrate that serum-mediated increase in glucose transport in human skeletal muscle cells is dependent on GLUT1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport / physiology*
  • Blood Proteins / metabolism*
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Female
  • Glucose / metabolism*
  • Glucose Transporter Type 1
  • Humans
  • Male
  • Middle Aged
  • Monosaccharide Transport Proteins / genetics
  • Monosaccharide Transport Proteins / metabolism*
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / metabolism*
  • RNA Interference*
  • RNA, Messenger / metabolism
  • Staining and Labeling / methods

Substances

  • Blood Proteins
  • Glucose Transporter Type 1
  • Monosaccharide Transport Proteins
  • RNA, Messenger
  • SLC2A1 protein, human
  • Glucose